ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly ...

Nel Hydrogen US, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a purchase order from Mesure Process, a subsidiary of ...

Nel ASA (Nel, OSE:NEL) will publish its first quarter 2026 report on 22 April 2026 at 07:00 CET, and will host a results ...

The sustainable bond market has matured into a key channel for financing green and social projects. However, it has also ...

Reference is made to the Annual General Meeting of Nel ASA (Nel, OSE:NEL) held today where the updated guidelines regarding ...

Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria. Approval in CSU for children two to ...

S&P Global Ratings has published a new Sustainability Insight assessing how the EU is recalibrating its sustainability ...

Euronext Oslo Børs has received an application for ISIN NO0013725747 to be admitted to stock exchange listing. The Market Abuse Regulation (MAR) applies from the time the application has been made, ...

Hamilton, Bermuda, 15 April 2026 – Reference is made to the summons to a written resolution dated 26 March 2026 regarding the request for ...

Reference is made to the stock exchange announcement made by Grieg Seafood ASA ("Grieg Seafood" or the "Company") on 27 March 2026 regarding ...

The first day of trading on Euronext Oslo Børs is expected to be 30 April 2026. The ticker STECH remains unchanged.